# Scenario 1
Base Rate (Prevalence): 0.05
Sensitivity: 0.41
Specificity: 0.95


#Scenario 2
Base Rate (Prevalence): 0.09
Sensitivity: 0.08
Specificity: 0.84


#Scenario 3
Row Used: Row 4 in the spreadsheet
Real Test Name: Compression Rotation
Real Condition: Superior Labral Anterior-Posterior Lesions
Prevalence: 0.10
Sensitivity: 0.24
Specificity: 0.76


#Scenario 4
Row Used: Row 8
Real Test Name: MRI observer 2
Real Condition: Invasive cervical carcinoma
Prevalence: 0.20
Sensitivity: 0.89
Specificity: 0.64

#Scenario 5
Row Used: Row 16
Real Test: Logistic regression 2
Real Condition: Ovarian cancer
Prevalence: 0.33
Sensitivity: 0.09
Specificity: 0.99

#Scenario 6
Row Used: Row 12
Real Test: MR arthrography reader 3
Real Condition: Superior labral anterior-posterior lesions
Prevalence: 0.31
Sensitivity: 0.84
Specificity: 0.69

#Scenario 7
Hypothetical Test Name: CerviCheck Reflex Screen
Hypothetical Condition: Deep Cervical Structural Syndrome
Prevalence: Moderate (actual: 0.20)
Sensitivity: Moderate (actual: 0.44)
Specificity: Very High / Perfect (actual: 1.00)
Source Row: Row 6 in your dataset
Original Test: Physical examination
Original Condition: Invasive cervical carcinoma




   {
        "id": 1,
        "title": "CerviMap Imaging",
        "description": "You recently underwent a scan called the NeuroGlow Imaging Series, which is used to detect a condition known as Glionova Mass Response — a brain-related condition involving abnormal tissue activity that can potentially grow or interfere with neural function. While not universal, this condition is relatively common in the population being screened with this test.\n\nThe NeuroGlow scan generally performs well in both detecting the condition when it's present and providing a negative result when it’s not. Like all medical tests, though, it is not flawless — there are still cases where the scan may give a false result, either positive or negative.\n\nYour NeuroGlow result came back positive. This means the test found something that, based on its design, is often seen in people who have Glionova Mass Response. However, the test result does not confirm or rule out the condition on its own. It reflects the general behavior of the test and is one part of a broader picture.\n\nUnderstanding how a result like this fits into your situation can be complex. It’s helpful to think about how often this condition shows up, and how this test usually performs, in order to interpret the result meaningfully."
      },